Bill Hoon Chang, M.D., Ph.D.

  • Professor of Pediatrics, Division of Hematology and Oncology, School of Medicine
  • Marsha and Richard Wright, Sr. Family Professor in Pediatric Oncology

Biography

Dr. Bill Chang cares for children, adolescents and young adults with cancer. He has special expertise in blood cancers. His research focuses on novel targets for therapy in blood cancers, including leukemia. He also teaches OHSU residents and fellows and mentors students and post-doctoral fellows within his research lab.

Dr. Chang is the director of the Leukemia and Lymphoma Program within OHSU's Division of Pediatric Hematology and Medical Oncology. He is also a member of OHSU's Pediatric Bone Marrow Transplant and Cellular Therapy Program.

When he's not working, Dr. Chang enjoys spending time with family and friends. He enjoys the outdoors, including mountain biking, alpine and backcountry skiing and hiking. He also enjoys "Airstreaming" – traveling by Airstream trailer.

Education and training

  • Degrees

    • B.S., 1991, University of Washington
    • Ph.D., 2000, Oregon Health & Science University
    • M.D., 2000, Oregon Health & Science University
  • Residency

    • Pediatrics, Oregon Health & Science University, 2003
  • Fellowship

    • Fellowship in Pediatric Hematology/Oncology, Oregon Health & Science University, 2006
  • Certifications

    • American Board of Pediatrics, 2003
    • American Board of Pediatrics, Pediatric Hematology and Oncology 2006

Memberships and associations:

  • American Academy of Pediatrics
  • American Association for Cancer Research
  • Children’s Oncology Group
  • American Society for Blood and Marrow Transplantation
  • American Society of Clinical Oncology
  • American Society of Hematology
  • American Society of Pediatric Hematology and Oncology

Areas of interest

  • Novel targeted therapies
  • Immunotherapies and Cellular Therapies
  • Hematopoietic Stem Cell Transplantation

Publications

Elsevier pure profile

Publications

  • Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML)

    Cancers
    1. Anupam Verma
    2. Yueh Yun Chi
    3. Jemily Malvar
    4. Adam Lamble
    5. Sonali Chaudhury
    6. Archana Agarwal
    7. Hong Tao Li
    8. Gangning Liang
    9. Roy Leong
    10. Patrick A. Brown
    11. Joel Kaplan
    12. Eric S. Schafer
    13. Tamra Slone
    14. Melinda Pauly
    15. Bill H. Chang
    16. Elliot Stieglitz
    17. Alan S. Wayne
    18. Nobuko Hijiya
    19. Deepa Bhojwani
  • The genomic basis of childhood T-lineage acute lymphoblastic leukaemia

    Nature
    1. Petri Pölönen
    2. Danika Di Giacomo
    3. Anna Eames Seffernick
    4. Abdelrahman Elsayed
    5. Shunsuke Kimura
    6. Francesca Benini
    7. Lindsey E. Montefiori
    8. Brent L. Wood
    9. Jason Xu
    10. Changya Chen
    11. Zhongshan Cheng
    12. Haley Newman
    13. Jason Myers
    14. Ilaria Iacobucci
    15. Elizabeth Li
    16. Jonathan Sussman
    17. Dale Hedges
    18. Yawei Hui
    19. Caroline Diorio
    20. Lahari Uppuluri
    21. David Frank
    22. Yiping Fan
    23. Yunchao Chang
    24. Soheil Meshinchi
    25. Rhonda Ries
    26. Rawan Shraim
    27. Alexander Li
    28. Kathrin M. Bernt
    29. Meenakshi Devidas
    30. Stuart S. Winter
    31. Kimberly P. Dunsmore
    32. Hiroto Inaba
    33. William L. Carroll
    34. Nilsa C. Ramirez
    35. Aaron H. Phillips
    36. Richard W. Kriwacki
    37. Jun J. Yang
    38. Tiffaney L. Vincent
    39. Yaqi Zhao
    40. Pankaj S. Ghate
    41. Jian Wang
    42. Colleen Reilly
    43. Xin Zhou
    44. Mathijs A. Sanders
    45. Junko Takita
    46. Motohiro Kato
    47. Nao Takasugi
    48. Bill H. Chang
    49. Richard D. Press
    50. Mignon Loh
    51. Evadnie Rampersaud
    52. Elizabeth Raetz
    53. Stephen P. Hunger
    54. Kai Tan
    55. Ti Cheng Chang
    56. Gang Wu
    57. Stanley B. Pounds
    58. Charles G. Mullighan
    59. David T. Teachey
  • Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy

    Blood cancer discovery
    1. Christopher A. Eide
    2. Stephen E. Kurtz
    3. Andy Kaempf
    4. Nicola Long
    5. Sunil Kumar Joshi
    6. Tamilla Nechiporuk
    7. Ariane Huang
    8. Charles A. Dibb
    9. Akosha Taylor
    10. Daniel Bottomly
    11. Shannon K. McWeeney
    12. Jessica Minnier
    13. Curtis A. Lachowiez
    14. Jennifer N. Saultz
    15. Ronan T. Swords
    16. Anupriya Agarwal
    17. Bill H. Chang
    18. Brian J. Druker
    19. Jeffrey W. Tyner
  • Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases

    Clinical Cancer Research
    1. Olivia M. Lucero
    2. Ji Ann Lee
    3. Jenna Bowman
    4. Kara Johnson
    5. Gopal Sapparapu
    6. John K. Thomas
    7. Guang Fan
    8. Bill H. Chang
    9. Karina Thiel-Klare
    10. Christopher A. Eide
    11. Craig Okada
    12. Mike Palazzolo
    13. Evan Lind
    14. Yoko Kosaka
    15. Brian J. Druker
    16. Nicholas Lydon
    17. Peter M. Bowers
  • Patients with Down syndrome can be included in early phase clinical trials- a report from the T2016-003 Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) study

    Leukemia
    1. N. Gossai
    2. D. Bhojwani
    3. E. S. Schafer
    4. B. H. Chang
    5. L. Pommert
    6. A. Verma
    7. J. Malvar
    8. Y. Y. Chi
    9. J. Hitzler
    10. M. J. Burke
    11. K. R. Rabin
  • Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia

    Blood Advances
    1. Stephen E. Kurtz
    2. Christopher A. Eide
    3. Andy Kaempf
    4. Nicola Long
    5. Daniel Bottomly
    6. Olga Nikolova
    7. Brian J. Druker
    8. Shannon K. McWeeney
    9. Bill H. Chang
    10. Jeffrey W. Tyner
    11. Anupriya Agarwal
  • Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML

    American Journal of Hematology
    1. Lauren Pommert
    2. Eric S. Schafer
    3. Jemily Malvar
    4. Nathan Gossai
    5. Ellynore Florendo
    6. Kirthi Pulakanti
    7. Katelyn Heimbruch
    8. Cary Stelloh
    9. Yueh Yun Chi
    10. Richard Sposto
    11. Sridhar Rao
    12. Van Thu Huynh
    13. Patrick Brown
    14. Bill H. Chang
    15. Susan I. Colace
    16. Michelle L. Hermiston
    17. Kenneth Heym
    18. Raymond J. Hutchinson
    19. Joel A. Kaplan
    20. Rajen Mody
    21. Tracey A. O'Brien
    22. Andrew E. Place
    23. Peter H. Shaw
    24. David S. Ziegler
    25. Alan Wayne
    26. Deepa Bhojwani
    27. Michael J. Burke
  • Fetal Hepatomegaly

    NeoReviews
    1. Jina Park
    2. Devlynne Sasha Ondusko
    3. Bill H. Chang
    4. Emily A. Edwards
    5. Sylvia Doan
    6. Ken Gatter
    7. Ibrahim Hajjali
    8. Amanda Kim
  • Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

    Cancer Cell
    1. Daniel Bottomly
    2. Nicola Long
    3. Anna Reister Schultz
    4. Stephen E. Kurtz
    5. Cristina E. Tognon
    6. Kara Johnson
    7. Melissa Abel
    8. Anupriya Agarwal
    9. Sammantha Avaylon
    10. Erik Benton
    11. Aurora Blucher
    12. Uma Borate
    13. Theodore P. Braun
    14. Jordana Brown
    15. Jade Bryant
    16. Russell Burke
    17. Amy Carlos
    18. Bill H. Chang
    19. Hyun Jun Cho
    20. Stephen Christy
    21. Cody Coblentz
    22. Aaron M. Cohen
    23. Amanda d'Almeida
    24. Rachel Cook
    25. Alexey Danilov
    26. Kim Hien T. Dao
    27. Michie Degnin
    28. James Dibb
    29. Christopher A. Eide
    30. Isabel English
    31. Stuart Hagler
    32. Heath Harrelson
    33. Rachel Henson
    34. Hibery Ho
    35. Sunil K. Joshi
    36. Brian Junio
    37. Andy Kaempf
    38. Yoko Kosaka
    39. Ted Laderas
    40. Matt Lawhead
    41. Hyunjung Lee
    42. Jessica T. Leonard
    43. Chenwei Lin
    44. Evan F. Lind
    45. Selina Qiuying Liu
    46. Pierrette Lo
    47. Marc M. Loriaux
    48. Samuel Luty
    49. Julia E. Maxson
    50. Tara Macey
    51. Jacqueline Martinez
    52. Jessica Minnier
    53. Andrea Monteblanco
    54. Motomi Mori
    55. Quinlan Morrow
    56. Dylan Nelson
    57. Justin Ramsdill
    58. Angela Rofelty
    59. Alexandra Rogers
    60. Kyle A. Romine
    61. Peter Ryabinin
    62. Jennifer N. Saultz
    63. David A. Sampson
    64. Samantha L. Savage
    65. Robert Schuff
    66. Robert Searles
    67. Rebecca L. Smith
    68. Stephen E. Spurgeon
    69. Tyler Sweeney
    70. Ronan T. Swords
    71. Aashis Thapa
    72. Karina Thiel-Klare
    73. Elie Traer
    74. Jake Wagner
    75. Beth Wilmot
    76. Joelle Wolf
    77. Guanming Wu
    78. Amy Yates
    79. Haijiao Zhang
    80. Christopher R. Cogle
    81. Robert H. Collins
    82. Michael W. Deininger
    83. Christopher S. Hourigan
    84. Craig T. Jordan
    85. Tara L. Lin
    86. Micaela E. Martinez
    87. Rachel R. Pallapati
    88. Daniel A. Pollyea
    89. Anthony D. Pomicter
    90. Justin M. Watts
    91. Scott J. Weir
    92. Brian J. Druker
    93. Shannon K. McWeeney
    94. Jeffrey W. Tyner
  • A phase 1 study of entinostat in children and adolescents with recurrent or refractory solid tumors, including CNS tumors

    Pediatric Blood and Cancer
    1. Andrew Bukowinski
    2. Bill Chang
    3. Joel M. Reid
    4. Xiaowei Liu
    5. Charles G. Minard
    6. Jane B. Trepel
    7. Min Jung Lee
    8. Elizabeth Fox
    9. Brenda J. Weigel
  • Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL

    Blood
    1. Jessica T. Leonard
    2. Yoko Kosaka
    3. Pavani Malla
    4. Dorian LaTocha
    5. Adam Lamble
    6. Brandon Hayes-Lattin
    7. Kaelan Byrd
    8. Brian J. Druker
    9. Jeffrey W. Tyner
    10. Bill H. Chang
    11. Evan Lind
  • Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia

    Clinical Cancer Research
    1. Michael J. Burke
    2. Rumen Kostadinov
    3. Richard Sposto
    4. Lia Gore
    5. Shannon M. Kelley
    6. Cara Rabik
    7. Jane B. Trepel
    8. Min Jung Lee
    9. Akira Yuno
    10. Sunmin Lee
    11. Deepa Bhojwani
    12. Sima Jeha
    13. Bill H. Chang
    14. Maria Luisa Sulis
    15. Michelle L. Hermiston
    16. Paul Gaynon
    17. Van Huynh
    18. Anupam Verma
    19. Rebecca Gardner
    20. Kenneth M. Heym
    21. Robyn M. Dennis
    22. David S. Ziegler
    23. Theodore W. Laetsch
    24. Javier E. Oesterheld
    25. Steven G. Dubois
    26. Jessica A. Pollard
    27. Julia Glade-Bender
    28. Todd M. Cooper
    29. Joel A. Kaplan
    30. Midhat S. Farooqi
    31. Byunggil Yoo
    32. Erin Guest
    33. Alan S. Wayne
    34. Patrick A. Brown
  • Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia

    Leukemia
    1. Christopher A. Eide
    2. Stephen E. Kurtz
    3. Andy Kaempf
    4. Nicola Long
    5. Anupriya Agarwal
    6. Cristina E. Tognon
    7. Motomi Mori
    8. Brian J. Druker
    9. Bill H. Chang
    10. Alexey V. Danilov
    11. Jeffrey W. Tyner
  • Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic niche

    EMBO Reports
    1. Sherif Abdelhamed
    2. John T. Butler
    3. Ben Doron
    4. Amber Halse
    5. Eneida Nemecek
    6. Phillip A. Wilmarth
    7. Daniel L. Marks
    8. Bill H. Chang
    9. Terzah Horton
    10. Peter Kurre
  • Replication timing alterations in leukemia affect clinically relevant chromosome domains

    Blood Advances
    1. Juan Carlos Rivera-Mulia
    2. Takayo Sasaki
    3. Claudia Trevilla-Garcia
    4. Naoto Nakamichi
    5. David J.H.F. Knapp
    6. Colin A. Hammond
    7. Bill H. Chang
    8. Jeffrey W. Tyner
    9. Meenakshi Devidas
    10. Jared Zimmerman
    11. Kyle N. Klein
    12. Vivek Somasundaram
    13. Brian J. Druker
    14. Tanja A. Gruber
    15. Amnon Koren
    16. Connie J. Eaves
    17. David M. Gilbert
  • The TP53 apoptotic network is a primary mediator of resistance to BCL2 inhibition in AML cells

    Cancer discovery
    1. Tamilla Nechiporuk
    2. Stephen E. Kurtz
    3. Olga Nikolova
    4. Tingting Liu
    5. Courtney L. Jones
    6. Angelo D’alessandro
    7. Rachel Culp-Hill
    8. Amanda D’almeida
    9. Sunil K. Joshi
    10. Mara Rosenberg
    11. Cristina E. Tognon
    12. Alexey V. Danilov
    13. Brian J. Druker
    14. Bill H. Chang
    15. Shannon K. McWeeney
    16. Jeffrey W. Tyner
  • Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome–positive acute lymphoblastic leukemia

    Journal of Clinical Oncology
    1. William B. Slayton
    2. Kirk R. Schultz
    3. John A. Kairalla
    4. Meenakshi Devidas
    5. Xinlei Mi
    6. Michael A. Pulsipher
    7. Bill H. Chang
    8. Charles Mullighan
    9. Ilaria Iacobucci
    10. Lewis B. Silverman
    11. Michael J. Borowitz
    12. Andrew J. Carroll
    13. Nyla A. Heerema
    14. Julie M. Gastier-Foster
    15. Brent L. Wood
    16. Sherri L. Mizrahy
    17. Thomas Merchant
    18. Valerie I. Brown
    19. Lance Sieger
    20. Marilyn J. Siegel
    21. Elizabeth A. Raetz
    22. Naomi J. Winick
    23. Mignon L. Loh
    24. William L. Carroll
    25. Stephen P. Hunger
  • Functional genomic landscape of acute myeloid leukaemia

    Nature
    1. Jeffrey W. Tyner
    2. Cristina E. Tognon
    3. Daniel Bottomly
    4. Beth Wilmot
    5. Stephen E. Kurtz
    6. Samantha L. Savage
    7. Nicola Long
    8. Anna Reister Schultz
    9. Elie Traer
    10. Melissa Abel
    11. Anupriya Agarwal
    12. Aurora Blucher
    13. Uma Borate
    14. Jade Bryant
    15. Russell Burke
    16. Amy Carlos
    17. Richie Carpenter
    18. Joseph Carroll
    19. Bill H. Chang
    20. Cody Coblentz
    21. Amanda d’Almeida
    22. Rachel Cook
    23. Alexey Danilov
    24. Kim Hien T. Dao
    25. Michie Degnin
    26. Deirdre Devine
    27. James Dibb
    28. David K. Edwards
    29. Christopher A. Eide
    30. Isabel English
    31. Jason Glover
    32. Rachel Henson
    33. Hibery Ho
    34. Abdusebur Jemal
    35. Kara Johnson
    36. Ryan Johnson
    37. Brian Junio
    38. Andy Kaempf
    39. Jessica Leonard
    40. Chenwei Lin
    41. Selina Qiuying Liu
    42. Pierrette Lo
    43. Marc M. Loriaux
    44. Samuel Luty
    45. Tara Macey
    46. Jason MacManiman
    47. Jacqueline Martinez
    48. Motomi Mori
    49. Dylan Nelson
    50. Ceilidh Nichols
    51. Jill Peters
    52. Justin Ramsdill
    53. Angela Rofelty
    54. Robert Schuff
    55. Robert Searles
    56. Erik Segerdell
    57. Rebecca L. Smith
    58. Stephen E. Spurgeon
    59. Tyler Sweeney
    60. Aashis Thapa
    61. Corinne Visser
    62. Jake Wagner
    63. Kevin Watanabe-Smith
    64. Kristen Werth
    65. Joelle Wolf
    66. Libbey White
    67. Amy Yates
    68. Haijiao Zhang
    69. Christopher R. Cogle
    70. Robert H. Collins
    71. Denise C. Connolly
    72. Michael W. Deininger
    73. Leylah Drusbosky
    74. Christopher S. Hourigan
    75. Craig T. Jordan
    76. Patricia Kropf
    77. Tara L. Lin
    78. Micaela E. Martinez
    79. Bruno C. Medeiros
    80. Rachel R. Pallapati
    81. Daniel A. Pollyea
    82. Ronan T. Swords
    83. Justin M. Watts
    84. Scott J. Weir
    85. David L. Wiest
    86. Ryan M. Winters
    87. Shannon K. McWeeney
    88. Brian J. Druker
  • Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL

    Oncogene
    1. Marilynn Chow
    2. Lina Gao
    3. Jason D. MacManiman
    4. Vincent T. Bicocca
    5. Bill H. Chang
    6. Joshi J. Alumkal
    7. Jeffrey W. Tyner
  • Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia

    Leukemia
    1. Weili Sun
    2. Jemily Malvar
    3. Richard Sposto
    4. Anupam Verma
    5. Jennifer J. Wilkes
    6. Robyn Dennis
    7. Kenneth Heym
    8. Theodore W. Laetsch
    9. Melissa Widener
    10. Susan R. Rheingold
    11. Javier Oesterheld
    12. Nobuko Hijiya
    13. Maria Luisa Sulis
    14. Van Huynh
    15. Andrew E. Place
    16. Henrique Bittencourt
    17. Raymond Hutchinson
    18. Yoav Messinger
    19. Bill Chang
    20. Yousif Matloub
    21. David S. Ziegler
    22. Rebecca Gardner
    23. Todd Cooper
    24. Francesco Ceppi
    25. Michelle Hermiston
    26. Luciano Dalla-Pozza
    27. Kirk R. Schultz
    28. Paul Gaynon
    29. Alan S. Wayne
    30. James A. Whitlock
  • Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia

    Science signaling
    1. Chelsea Jenkins
    2. Samuel B. Luty
    3. Julia E. Maxson
    4. Christopher A. Eide
    5. Melissa L. Abel
    6. Corinne Togiai
    7. Eneida R. Nemecek
    8. Daniel Bottomly
    9. Shannon K. McWeeney
    10. Beth Wilmot
    11. Marc Loriaux
    12. Bill H. Chang
    13. Jeffrey W. Tyner
  • Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes

    Journal of Clinical Investigation
    1. Carlos A. Ramos
    2. Brandon Ballard
    3. Huimin Zhang
    4. Olga Dakhova
    5. Adrian P. Gee
    6. Zhuyong Mei
    7. Mrinalini Bilgi
    8. Meng Fen Wu
    9. Hao Liu
    10. Bambi Grilley
    11. Catherine M. Bollard
    12. Bill H. Chang
    13. Cliona M. Rooney
    14. Malcolm K. Brenner
    15. Helen E. Heslop
    16. Gianpietro Dotti
    17. Barbara Savoldo
  • Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia

    Blood
    1. Viktoras Frismantas
    2. Maria Pamela Dobay
    3. Anna Rinaldi
    4. Joelle Tchinda
    5. Samuel H. Dunn
    6. Joachim Kunz
    7. Paulina Richter-Pechanska
    8. Blerim Marovca
    9. Orrin Pail
    10. Silvia Jenni
    11. Ernesto Diaz-Flores
    12. Bill H. Chang
    13. Timothy J. Brown
    14. Robert H. Collins
    15. Sebastian Uhrig
    16. Gnana P. Balasubramanian
    17. Obul R. Bandapalli
    18. Salome Higi
    19. Sabrina Eugster
    20. Pamela Voegeli
    21. Mauro Delorenzi
    22. Gunnar Cario
    23. Mignon L. Loh
    24. Martin Schrappe
    25. Martin Stanulla
    26. Andreas E. Kulozik
    27. Martina U. Muckenthaler
    28. Vaskar Saha
    29. Julie A. Irving
    30. Roland Meisel
    31. Thomas Radimerski
    32. Arend Von Stackelberg
    33. Cornelia Eckert
    34. Jeffrey W. Tyner
    35. Peter Horvath
    36. Beat C. Bornhauser
    37. Jean Pierre Bourquin
  • Investigating the biology of relapsed acute leukemia

    Pediatric Hematology and Oncology
    1. Deepa Bhojwani
    2. Michael J. Burke
    3. Terzah Horton
    4. David S. Ziegler
    5. Maria Luisa Sulis
    6. Kirk R. Schultz
    7. Alan Wayne
    8. Shai Izraeli
    9. Bill H. Chang